PMID: 25764686Mar 15, 2015Paper

Treatment for chronic hepatitis C with thrombocytopenia

Nihon rinsho. Japanese journal of clinical medicine
Norihiro FurusyoJun Hayashi

Abstract

Thrombocytopenia in patients with chronic hepatitis C represents an obstacle for the initiation of antiviral treatment. Antiviral treatment with pegylated interferon α and ribavirin has contributed to a significant increase in the rate of sustained virological response. However, patients with thrombocytopenia is ineligible for antiviral treatment or, if able to start treatment, may require a dose reduction or even discontinuation due to the haematological adverse effects. We here review the efficacy and safety of antiviral treatment after splenectomy and partial splenic embolization, and the potential effect of platelet count increase by interferon β.

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.